Prestin as an Early Biomarker of Hearing Loss in Nasopharyngeal Cancer Patients Undergoing Induction Chemoradiation

<b>Background/Objectives:</b> Nasopharyngeal cancer (NPC) is prevalent in Southeast Asia, Southern China and North Africa. Up to 46% of NPC patients undergoing cisplatin chemoradiation treatment experience irreversible hearing loss. Prestin is a motor protein in the outer hair cells of the cochlea,...

詳細記述

書誌詳細

主要な著者:	Vanessa Y. J. Tan, Ng Jia Hui, Kiattisa Sommat, Thong Jiun Fong, Edward Z. Y. Zhang, Lai Oi Fah, Chia Xin Ni, Ang Mei Kim, Ong Ni Gin, Lim Chwee Ming
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2026-03-01
シリーズ:	Journal of Otorhinolaryngology, Hearing and Balance Medicine
主題:	ototoxicity biomarker cancer prestin hearing loss tinnitus
オンライン･アクセス:	https://www.mdpi.com/2504-463X/7/1/14
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!